NCT04509089View on ClinicalTrials.gov

Establishing Correlation Between Non-invasive Pulmonary Blood Pressure Readings and Swan-Ganz Results

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

January 29, 2021

Study Completion Date

March 1, 2021

Conditions
Congestive Heart Failure
Interventions
DEVICE

Suremedix Device

Performing measurements using the Suremedix Device by applying gradually ascending air pressure to the subject lungs through a mouse piece while measuring respiratory chest motion, PPG and ECG.

Trial Locations (1)

49100

Rabin Medical Center, Petah Tikva

All Listed Sponsors
lead

Suremedix Ltd

INDUSTRY

NCT04509089 - Establishing Correlation Between Non-invasive Pulmonary Blood Pressure Readings and Swan-Ganz Results | Biotech Hunter | Biotech Hunter